• 1
    Tack J, Talley NJ, Camilleri M et al. Functional gastroduodenal disorders. Gastroenterology 2006; 130: 146679.
  • 2
    Tack J, Bisschops R, Sarnelli G. Pathophysiology and treatment of functional dyspepsia. Gastroenterology 2004; 127: 123955.
  • 3
    Westbrook JI, Talley NJ. Empiric clustering of dyspepsia into symptom subgroups: a population-based study. Scand J Gastroenterol 2002; 37: 91723.
  • 4
    Tack J, Jones MP, Karamanolis G, Coulie B, Dubois D. Symptom pattern and pathophysiological correlates of weight loss in tertiary-referred functional dyspepsia. Neurogastroenterol Motil 2009; 22: 29e25.
  • 5
    Jones MP, Talley NJ, Eslick GD, Dubois D, Tack J. Community subgroups in dyspepsia and their association with weight loss. Am J Gastroenterol 2008; 103: 205160.
    Direct Link:
  • 6
    Van Oudenhove L, Aziz Q. Recent insights on central processing and psychological processes in functional gastrointestinal disorders. Dig Liver Dis 2009; 41: 7817.
  • 7
    Levy RL, Olden KW, Naliboff BD et al. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology 2006; 130: 144758.
  • 8
    Löwe B, Mundt C, Herzog W et al. Validity of current somatoform disorder diagnoses: perspectives for classification in DSM-V and ICD-11. Psychopathology 2008; 41: 49.
  • 9
    Sharpe M, Mayou R, Walker J. Bodily symptoms: new approaches to classification. J Psychosom Res 2006; 60: 3536.
  • 10
    Mayou R, Kirmayer LJ, Simon G, Kroenke K, Sharpe M. Somatoform disorders: time for a new approach in DSM-V. Am J Psychiatry 2005; 162: 84755.
  • 11
    Rief W, Rojas G. Stability of somatoform symptoms implications for classification. Psychosom Med 2007; 69: 8649.
  • 12
    De Gucht V, Fischler B. Somatization: a critical review of conceptual and methodological issues. Psychosomatics 2002; 43: 19.
  • 13
    Van Oudenhove L, Vandenberghe J, Geeraerts B et al. Determinants of symptoms in functional dyspepsia: gastric sensorimotor function, psychosocial factors or somatization? Gut 2008; 57: 166673.
  • 14
    Van Oudenhove L, Vandenberghe J, Vos R, Holvoet L, Demyttenaere K, Tack J. Risk factors for impaired health-related quality of life in functional dyspepsia. Aliment Pharmacol Ther 2010; 33: 26174.
  • 15
    Giesecke T, Williams DA, Harris RE et al. Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis Rheum 2003; 48: 291622.
  • 16
    Cuomo R, Sarnelli G, Grasso R et al. Functional dyspepsia symptoms, gastric emptying and satiety provocative test: analysis of relationships. Scand J Gastroenterol 2001; 36: 10306.
  • 17
    Van Oudenhove L, Vandenberghe J, Geeraerts B et al. Relationship between anxiety and gastric sensorimotor function in functional dyspepsia. Psychosom Med 2007; 69: 45563.
  • 18
    Fischler B, Tack J, De Gucht V et al. Heterogeneity of symptom pattern, psychosocial factors, and pathophysiological mechanisms in severe functional dyspepsia. Gastroenterology 2003; 124: 90310.
  • 19
    Sarnelli G, Caenepeel P, Geypens B, Janssens J, Tack J. Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol 2003; 98: 7838.
    Direct Link:
  • 20
    Corsetti M, Caenepeel P, Fischler B, Janssens J, Tack J. Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia. Am J Gastroenterol 2004; 99: 11529.
    Direct Link:
  • 21
    Spielberger C, Gorsuch R, Lushene R, Vagg P, Jacobs G. Manual for the State – Trait Anxiety Inventory (Form Y Self-Evaluation Questionnaire). Palo Alto, CA: Consulting Psychologists Press, 1983.
  • 22
    Van der Ploeg H. Handleiding bij de Zelf-Beoordelings Vragenlijst [Manual for the Dutch Adaptation of the STAI-Y], 2nd edn. Lisse: Swets & Zeitlinger, 2000.
  • 23
    Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 36170.
  • 24
    Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 1997; 27: 36370.
  • 25
    Kroenke K, Spitzer RL, Williams JBW. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002; 64: 25866.
  • 26
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994.
  • 27
    Lipowski ZJ. Somatization: the concept and its clinical application. Am J Psychiatry 1988; 145: 135868.
  • 28
    Kroenke K, Spitzer RL, deGruy FV III, Swindle R. A symptom checklist to screen for somatoform disorders in primary care. Psychosomatics 1998; 39: 26372.
  • 29
    Creed F. Can DSM-V facilitate productive research into the somatoform disorders? J Psychosom Res 2006; 60: 3314.
  • 30
    Kroenke K. Physical symptom disorder: a simpler diagnostic category for somatization-spectrum conditions. J Psychosom Res 2006; 60: 3359.
  • 31
    Barsky AJ, Orav EJ, Bates DW. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry 2005; 62: 90310.
  • 32
    Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GNJ. Functional gastroduodenal disorders. Gut 1999; 45: 37ii42.
  • 33
    Camilleri M, Dubois D, Coulie B et al. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol 2005; 3: 54352.
  • 34
    Agréus L, Svärdsudd K, Nyrén O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995; 109: 67180.
  • 35
    Kwan AC-P, Bao TN, Chakkaphak S et al. Validation of Rome II criteria for functional gastrointestinal disorders by factor analysis of symptoms in Asian patient sample. J Gastroenterol Hepatol 2003; 18: 796802.
  • 36
    Whitehead WE, Bassotti G, Palsson O, Taub E, Cook EC, Drossman DA. Factor analysis of bowel symptoms in US and Italian populations. Dig Liver Dis 2003; 35: 77483.
  • 37
    Laheij RJF, de Koning RW, Horrevorts AM et al. Predominant symptom behavior in patients with persistent dyspepsia during treatment. J Clin Gastroenterol 2004; 38: 4905.
  • 38
    De Gucht V, Maes S. Explaining medically unexplained symptoms: toward a multidimensional, theory-based approach to somatization. J Psychosom Res 2006; 60: 34952.
  • 39
    Naliboff BD. Towards a non-dualistic approach to multisystem illness. Am J Gastroenterol 2007; 102: 277780.
    Direct Link:
  • 40
    Anand P, Aziz Q, Willert R, Van Oudenhove L. Peripheral and central mechanisms of visceral sensitization in man. Neurogastroenterol Motil 2007; 19(Suppl. 1): 2946.
  • 41
    Whitehead WE, Palsson OS, Levy RR, Feld AD, Turner M, Von Korff M. Comorbidity in irritable bowel syndrome. Am J Gastroenterol 2007; 102: 276776.
    Direct Link:
  • 42
    Creed F, Guthrie E, Ratcliffe J et al. Does psychological treatment help only those patients with severe irritable bowel syndrome who also have a concurrent psychiatric disorder? Aust NZ J Psychiatry 2005; 39: 80715.
  • 43
    Creed F, Tomenson B, Guthrie E et al. The relationship between somatisation and outcome in patients with severe irritable bowel syndrome. J Psychosom Res 2008; 64: 61320.
  • 44
    Hamilton WT, Gallagher AM, Thomas JM, White PD. Risk markers for both chronic fatigue and irritable bowel syndromes: a prospective case-control study in primary care. Psychol Med 2009; 39: 191321.
  • 45
    Kanaan RAA, Lepine JP, Wessely SC. The Association or Otherwise of the Functional Somatic Syndromes. Psychosom Med 2007; 69: 8559.
  • 46
    Moss-Morris R, Spence M. To ‘Lump’ or to ‘Split’ the functional somatic syndromes: can infectious and emotional risk factors differentiate between the onset of chronic fatigue syndrome and irritable bowel syndrome? Psychosom Med 2006; 68: 4639.
  • 47
    Farmer AD, Aziz Q, Tack J, Van Oudenhove L. The future of neuroscientific research in functional gastrointestinal disorders: integration towards multidimensional (visceral) pain endophenotypes? J Psychosom Res 2010; 68: 47581.